Events

How does healthcare remain equally attractive for service providers, payers, patients and the industry? Reform and investment, so far the consensus, but how exactly? What is needed now is a clever agenda setting and an exchange of innovations at all levels of the industry between business, science and politics: this event offers the platform for this.

The Handelsblatt Biotech Conference brings together decision-makers from business, politics and science to discuss regulatory decisions, successful partnerships and investment strategies. Use the platform for exchange, insights and networking – for a strong biotech future "made in Europe".

Join global healthcare leaders as they convene at ISPOR Europe 2025, the leading global conference in Europe for Health Economics and Outcomes Research (HEOR) for discussion and dissemination of the latest trends in healthcare. This must-attend event provides you with dedicated opportunities to network with your peers, HEOR experts, and thought leaders and to discuss with a global audience how we establish, incentivize, and share value sustainable for health systems, patients, and technology developers.

The Global Pharma and Biotech Summit is the essential event for you to explore era-defining trends and developments in healthcare and life sciences. Distinguished innovators, investors and C-suite executives will discuss what’s new in key areas such as drug discovery, clinical trials, market access and patient engagement.

Three days of facts, news, discussions and lots of networking. More than 180 participants in the auditorium and over 40 experts on stage

Meet the leaders and decision-makers who are shaping the future of generics and biosimilars. Be inspired by new experiences, real talk and fresh ideas during a period of intense challenges and exciting promise. Join generic and biosimilar industry professionals at Access! 2026.

World Evidence, Pricing and Access Congress is Europe’s largest congress in market access, pricing and evidence featuring 300 speakers, 8 tracks and 1500+ attendees from pharma, biotech and Payers/HTAs.

The AMR Conference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and specific challenges faced by the innovation ecosystem in bringing new antimicrobial treatments and diagnostics to the market. The conference is the one-stop shop to catch up with the latest trends in the development of AMR products, by covering scientific, regulatory, financial and policy topics.

The Advanced Therapies Congress brings together speakers from across the entire value chain of cell and gene therapy development, forward-thinking pharma, biotech and start-up companies, researchers, clinicians, academics, HTAs, payers and regulators.

BioTrinity is OBN's flagship two-day conference for the life sciences industry, designed to catalyse growth for all who attend. The delegate mix comprises early stage and emerging life sciences R&D companies, investors, big pharma, academics, charities, government, and broad range of valued service providers.

The ABPI exists to make the UK the best place in the world to research, develop and access medicines and vaccines to improve patient care. We represent companies of all sizes which invest in making and discovering medicines and vaccines to enhance and save the lives of millions of people around the world.

Europe's premier conference in the cell and gene therapy industry today.